Related Experiment Video
Updated: Apr 3, 2026

07:35
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
43.3K
[The metastatic niche. Mechanisms and prognostic implications]
1Institut für Pathologie, Universitätsklinikum "Carl Gustav Carus" an der TU Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland. michael.muders@uniklinikum-dresden.de.
Der Pathologe
|September 24, 2015
Summary
Disseminated tumor cells form metastases in organ-specific niches, involving vascular remodeling and cell migration. The CXCL12-CXCR4 axis is crucial for this process and offers therapeutic targets.
Area of Science:
- Oncology
- Cell Biology
- Cancer Metastasis Research
Background:
- Metastasis formation requires a specific microenvironment, termed the metastatic niche, which is organ-specific and precedes macroscopic metastasis.
- Intranodal lymphangiogenesis is a key factor in regional lymph node metastasis for rectal cancer patients, serving as a prognostic marker.
- Niche cells secrete factors like CXCL12 that attract tumor and bone marrow-derived cells, facilitating metastasis.
Purpose of the Study:
- To review the function and regulation of the CXCL12-CXCR4 axis in metastasis formation.
- To discuss the role of the metastatic niche and its cellular components in cancer progression.
- To explore potential therapeutic strategies targeting the CXCL12-CXCR4 pathway.
Main Methods:
- Literature review of studies on metastatic niches, lymphangiogenesis, and the CXCL12-CXCR4 axis.
- Analysis of existing data on intranodal lymphangiogenesis as a prognostic marker in rectal cancer.
- Discussion of factors influencing CXCR4 expression and function, such as hypoxia.
Main Results:
- The metastatic niche is characterized by vascular remodeling and infiltration of bone marrow-derived cells.
- Intranodal lymphangiogenesis is a prerequisite for lymph node metastasis in rectal cancer and predicts survival.
- CXCL12, secreted by niche cells, activates CXCR4 on tumor cells, promoting migration along its gradient.
Conclusions:
- The CXCL12-CXCR4 axis plays a critical role in the formation of metastatic niches and subsequent metastasis.
- Targeting the CXCL12-CXCR4 pathway presents a promising therapeutic avenue for preventing or treating cancer metastasis.
- Understanding the metastatic niche and its regulation is essential for developing effective anti-metastatic strategies.
Related Concept Videos
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Tumor Progression
7.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K

